Skip to main content

Advertisement

Table 1 Model parameters

From: Shifting breast cancer surveillance from current hospital setting to a community based setting: a cost-effectiveness study

Parameter Input Source
Risk on LRR, year 2–5   Witteveen et al. [18]
• Low risk Yr 2: 0.0003, Yr 3: 0.0006, Yr 4: 0.0002, Yr 5: 0.0011
• High risk Yr 2: 0.0204, Yr 3: 0.0345, Yr 4: 0.0076, Yr 5: 0.0086
Sensitivity 0.654 (95%CI: 0.61–0.69) Houssami et al. [20]
Specificity 0.983 (95%CI: 0.982–0.984)
Costs per unit (€)
Cost of examination in NSP (mammography) 64.00 (25% range: €48 - €80) RIVM [17]
Cost of examination in hospital (mammography) 82.89 (25% range: €62 - €104) Calculation from publicly accessible hospital price lists for 2013.
Cost of add. examination in hospital after false positive result 926.83 (25% range: €695 - €1185)
Treatment costs for early detected LRR 9705 (25% range: €7280 – €12,122)
Treatment costs for late detected LRR 15,515 (25% range: €11,640 – €19.,384)